Hercules Capital is a venture lending and growth capital firm focused on financing innovative, venture-backed technology and life sciences companies. It provides structured debt and flexible financing, often alongside venture capital partners.
UpMarket does not offer Hercules Capital shares. This page covers Hercules Capital's history before it went public.
Hercules Capital became a public company on June 9, 2005 and trades on NYSE as HTGC. UpMarket does not offer Hercules Capital shares. This page covers Hercules Capital's valuation and funding history before it went public.
Hercules Capital listed on NYSE under the ticker HTGC on June 9, 2005.
See how Hercules Capital's private-market valuation changed across funding rounds before it went public.
See reported funding rounds and revenue figures on this page, with their sources.
Accredited investors can review UpMarket's current pre-IPO offerings in companies that have not yet gone public.
Pre-IPO investments are illiquid, speculative, and involve risk of total loss of capital.
| Date | Round | PPS (split-adj.) | Valuation |
|---|---|---|---|
| Jun 2005 | IPO | $13.00 |
Hercules says it has made commitments of more than $2.6 billion to more than 180 companies since inception. That scale positions it as a large lender to venture and private equity-backed startups.
Hunterbrook says Hercules has cited a cumulative net realized loss rate of only 3 basis points across $21.6 billion in total commitments since inception. The firm also says it funded 408 companies over the last 16 quarters, with 36% as new relationships.
Hercules describes itself as the largest publicly traded specialty finance company serving venture capital and private equity-backed companies. Its own site also calls it the largest business development company focused on venture lending.
Looking for companies that are still private? Browse UpMarket's pre-IPO company directory. Accredited investors only.
Browse the directory →UpMarket curates and conducts independent diligence on every investment opportunity before it reaches the platform.
We review every offering's strategy, risk management, liquidity, fees, valuation methodology, tax matters, and all third-party providers: legal counsel, auditor, administrator, and custodian.
We offer investments exclusively from disciplined managers that pursue unique strategies across an array of asset classes.
Our goal is to empower you to build a portfolio that best meets your individual investment objectives.
Yes. Hercules Capital became a public company on June 9, 2005 and trades on NYSE under the ticker HTGC. UpMarket does not offer Hercules Capital shares.
Hercules Capital's share price is set on the public market under the ticker HTGC. The prices shown on this page are historical private-market prices from before it went public.
No. Hercules Capital is now a public company and UpMarket does not offer its shares. Accredited investors interested in companies that have not yet gone public can review UpMarket's current pre-IPO offerings.
Hercules Capital is now publicly traded, so its shares can be bought and sold on NYSE and their price can change significantly. Review Hercules Capital's public filings and consult a financial advisor before investing. UpMarket does not offer Hercules Capital shares.
In a pre-IPO transaction, accredited investors purchase shares from existing shareholders (such as employees, early investors, or other holders) through secondary market platforms. The company itself does not issue new shares in these transactions. UpMarket facilitates these trades as a FINRA-registered broker-dealer, handling compliance, documentation, and settlement on behalf of both parties.
Hercules Capital became a public company on June 9, 2005, so shares held before the listing can generally be sold on the public market once any lock-up period ends. The exact terms depend on how the shares are held, for example directly or through a fund.
UpMarket does not offer Hercules Capital shares. The minimum for most pre-IPO offerings on UpMarket is $50,000.
Hercules Capital's valuation is now set by its public share price on NYSE. The figures on this page show its valuation history before it went public.
Hercules Capital has committed over $2.6 billion to 180+ venture-backed technology and life sciences companies, expanding its portfolio of structured debt and growth capital investments. Hercules Capital is now a public company, and UpMarket does not offer its shares.